Meg Marshall
2022
In 2022, Meg Marshall earned a total compensation of $922.1K as Chief Medical Officer at Barinthus Biotherapeutics plc., a 71% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $157,310 |
|---|---|
| Option Awards | $260,014 |
| Salary | $462,676 |
| Other | $42,055 |
| Total | $922,055 |
Marshall received $462.7K in salary, accounting for 50% of the total pay in 2022.
Marshall also received $157.3K in non-equity incentive plan, $260K in option awards and $42.1K in other compensation.
Rankings
In 2022, Meg Marshall's compensation ranked 3,211th out of 5,760 executives tracked by ExecPay. In other words, Marshall earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,211 out of 5,760 | 44th |
Division Manufacturing | 1,806 out of 3,136 | 42nd |
Major group Chemicals And Allied Products | 858 out of 1,422 | 40th |
Industry group Drugs | 802 out of 1,323 | 39th |
Industry Pharmaceutical Preparations | 585 out of 969 | 40th |
Source: SEC filing on March 29, 2023.
Marshall's colleagues
We found three more compensation records of executives who worked with Meg Marshall at Barinthus Biotherapeutics plc. in 2022.